ECSP088081A - Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente - Google Patents
Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondienteInfo
- Publication number
- ECSP088081A ECSP088081A EC2008008081A ECSP088081A ECSP088081A EC SP088081 A ECSP088081 A EC SP088081A EC 2008008081 A EC2008008081 A EC 2008008081A EC SP088081 A ECSP088081 A EC SP088081A EC SP088081 A ECSP088081 A EC SP088081A
- Authority
- EC
- Ecuador
- Prior art keywords
- therapeutic antibody
- detection
- diana
- ancient
- absence
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
Abstract
La presente invención está relacionada con el campo de los anticuerpos terapéuticos. La invención especialmente está relacionada con un método para la detección del antígeno diana de un anticuerpo terapéutico en una muestra que consiste en los siguientes pasos: a) proporcionar la muestra a analizar, b) incubar dicha muestra con dicho anticuerpo terapéutico bajo las condiciones apropiadas para unir dicho anticuerpo terapéutico a dicho antígeno diana, de manera que se forma un complejo de antígeno diana-anticuerpo terapéutico y c) detectar el complejo formado en (b).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05014618 | 2005-07-06 | ||
EP06004447 | 2006-03-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088081A true ECSP088081A (es) | 2008-02-20 |
Family
ID=36922121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008081A ECSP088081A (es) | 2005-07-06 | 2008-01-04 | Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070009976A1 (es) |
EP (2) | EP1902315A1 (es) |
JP (1) | JP2008545145A (es) |
KR (1) | KR20080016939A (es) |
AR (1) | AR053948A1 (es) |
AU (1) | AU2006265275A1 (es) |
BR (1) | BRPI0612591A2 (es) |
CA (1) | CA2613187A1 (es) |
CR (1) | CR9635A (es) |
EC (1) | ECSP088081A (es) |
IL (1) | IL188317A0 (es) |
MA (1) | MA29730B1 (es) |
MX (1) | MX2008000277A (es) |
MY (1) | MY157955A (es) |
NO (1) | NO20076662L (es) |
NZ (1) | NZ564471A (es) |
RU (1) | RU2008103608A (es) |
TW (1) | TWI312864B (es) |
WO (1) | WO2007003420A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030007640A (ko) | 2000-05-19 | 2003-01-23 | 제넨테크, 인크. | ErbB 길항제에 의한 암 치료요법에 대한 효과적인반응의 가능성을 개선시키기 위한 유전자 검출 분석 |
BRPI0513681A (pt) * | 2004-07-22 | 2008-05-13 | Genentech Inc | composição que compreendem anticorpo her2, método, formulações farmacêuticas, polipeptìdeo, anticorpo e método de tratamento de cáncer |
WO2006039486A2 (en) | 2004-10-01 | 2006-04-13 | The Board Of Trustees Of The Leland Stanford Junior University | Imaging arrangements and methods therefor |
JO3000B1 (ar) * | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
RU2404806C2 (ru) | 2005-02-23 | 2010-11-27 | Дженентек, Инк. | Продление времени до прогрессирования заболевания или продолжительности жизни у онкологических больных с применением ингибиторов димеризации her |
PE20070207A1 (es) * | 2005-07-22 | 2007-03-09 | Genentech Inc | Tratamiento combinado de los tumores que expresan el her |
US8248515B2 (en) | 2006-02-07 | 2012-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Variable imaging arrangements and methods therefor |
US8358354B2 (en) | 2009-01-26 | 2013-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Correction of optical abberations |
CL2008000614A1 (es) | 2007-03-02 | 2008-09-05 | Genentech Inc F Hoffmann La Ro | Metodo para tratar un paciente con un tipo de cancer que expresa el receptor her3 a un nivel bajo mediante la administracion de un inhibidor de la dimerizacion de her. |
TWI472339B (zh) | 2008-01-30 | 2015-02-11 | Genentech Inc | 包含結合至her2結構域ii之抗體及其酸性變異體的組合物 |
BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
CN117018187A (zh) | 2011-10-14 | 2023-11-10 | 霍夫曼-拉罗奇有限公司 | Her2二聚化抑制剂帕妥珠单抗的用途和包含her2二聚化抑制剂帕妥珠单抗的制品 |
KR101327542B1 (ko) * | 2012-03-15 | 2013-11-08 | 광주과학기술원 | 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법 |
AU2012232949B2 (en) * | 2012-09-28 | 2014-07-03 | Willowtree Holdings Pty Ltd | Temporary bulkhead |
BR112015024926A2 (pt) | 2013-04-16 | 2017-10-10 | Genentech Inc | composições, artigo de fabricação, métodos para tratar um paciente com câncer, para avaliar uma composição, para avaliar a atividade biológica, para produzir uma composição e para avaliar a fragmentação de uma composição e variante de pertuzumabe |
CN106163558A (zh) | 2014-04-25 | 2016-11-23 | 豪夫迈·罗氏有限公司 | 用曲妥珠单抗‑mcc‑dm1和帕妥珠单抗治疗早期乳腺癌的方法 |
WO2016196373A2 (en) | 2015-05-30 | 2016-12-08 | Genentech, Inc. | Methods of treating her2-positive metastatic breast cancer |
WO2017087280A1 (en) | 2015-11-16 | 2017-05-26 | Genentech, Inc. | Methods of treating her2-positive cancer |
CA3046092A1 (en) | 2016-12-28 | 2018-07-05 | Genentech, Inc. | Treatment of advanced her2 expressing cancer |
KR20200113292A (ko) | 2017-01-17 | 2020-10-06 | 제넨테크, 인크. | 피하 her2 항체 제형 |
US11077189B2 (en) | 2017-03-02 | 2021-08-03 | Genentech Inc. | Adjuvant treatment of HER2-positive breast cancer |
CN110536969A (zh) | 2017-04-24 | 2019-12-03 | 豪夫迈·罗氏有限公司 | 跨膜或近膜域中的erbb2/her2突变 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2095818B (en) | 1981-03-27 | 1985-10-02 | Exxon Research Engineering Co | Staged adsorption/resorption heat pump |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
ATE255131T1 (de) * | 1991-06-14 | 2003-12-15 | Genentech Inc | Humanisierter heregulin antikörper |
AU4025193A (en) | 1992-04-08 | 1993-11-18 | Cetus Oncology Corporation | Humanized C-erbB-2 specific antibodies |
IL129354A0 (en) | 1996-10-18 | 2000-02-17 | Genentech Inc | Anti-ErbB2 antibodies |
EP2131198B1 (en) | 2001-09-20 | 2013-03-27 | Board of Regents, The University of Texas System | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
PT1585966E (pt) * | 2002-07-15 | 2012-02-20 | Hoffmann La Roche | Tratamento de cancro com o anticorpo anti-erbb2 rhumab 2c4 |
-
2006
- 2006-06-29 MY MYPI20063118A patent/MY157955A/en unknown
- 2006-06-29 US US11/477,772 patent/US20070009976A1/en not_active Abandoned
- 2006-07-04 AR ARP060102872A patent/AR053948A1/es not_active Application Discontinuation
- 2006-07-04 TW TW095124248A patent/TWI312864B/zh active
- 2006-07-05 WO PCT/EP2006/006524 patent/WO2007003420A1/en active Application Filing
- 2006-07-05 CA CA002613187A patent/CA2613187A1/en not_active Abandoned
- 2006-07-05 MX MX2008000277A patent/MX2008000277A/es not_active Application Discontinuation
- 2006-07-05 KR KR1020087000259A patent/KR20080016939A/ko active Search and Examination
- 2006-07-05 BR BRPI0612591-3A patent/BRPI0612591A2/pt not_active IP Right Cessation
- 2006-07-05 JP JP2008519853A patent/JP2008545145A/ja active Pending
- 2006-07-05 EP EP06754671A patent/EP1902315A1/en not_active Withdrawn
- 2006-07-05 NZ NZ564471A patent/NZ564471A/en unknown
- 2006-07-05 RU RU2008103608/15A patent/RU2008103608A/ru unknown
- 2006-07-05 AU AU2006265275A patent/AU2006265275A1/en not_active Abandoned
- 2006-07-05 EP EP10157725A patent/EP2194380A3/en not_active Withdrawn
-
2007
- 2007-12-20 IL IL188317A patent/IL188317A0/en unknown
- 2007-12-21 CR CR9635A patent/CR9635A/es not_active Application Discontinuation
- 2007-12-28 NO NO20076662A patent/NO20076662L/no not_active Application Discontinuation
-
2008
- 2008-01-04 EC EC2008008081A patent/ECSP088081A/es unknown
- 2008-02-01 MA MA30617A patent/MA29730B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2006265275A1 (en) | 2007-01-11 |
RU2008103608A (ru) | 2009-08-20 |
NO20076662L (no) | 2008-04-03 |
EP2194380A3 (en) | 2010-07-14 |
EP1902315A1 (en) | 2008-03-26 |
KR20080016939A (ko) | 2008-02-22 |
CR9635A (es) | 2008-02-20 |
IL188317A0 (en) | 2008-04-13 |
MA29730B1 (fr) | 2008-09-01 |
JP2008545145A (ja) | 2008-12-11 |
MX2008000277A (es) | 2008-03-24 |
US20070009976A1 (en) | 2007-01-11 |
BRPI0612591A2 (pt) | 2010-11-23 |
EP2194380A2 (en) | 2010-06-09 |
NZ564471A (en) | 2010-04-30 |
TWI312864B (en) | 2009-08-01 |
TW200741203A (en) | 2007-11-01 |
WO2007003420A1 (en) | 2007-01-11 |
AR053948A1 (es) | 2007-05-23 |
CA2613187A1 (en) | 2007-01-11 |
MY157955A (en) | 2016-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088081A (es) | Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente | |
EP4249605A3 (en) | Methods for analyte detection | |
MX362075B (es) | Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo. | |
TW200801202A (en) | Alpha-enolase specific antibody and method of use | |
ES2528321T3 (es) | Detección de a-fucosilación en anticuerpos | |
WO2013068374A3 (en) | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment | |
NZ609824A (en) | Immunochromatography devices, methods and kits | |
EP4273551A3 (en) | Multiplexed total antibody and antibody-conjugated drug quantification assay | |
BR112018005812A2 (pt) | ?método de imunoensaio para a detecção de um analito, kit de reagentes para detectar um analito por um imunoensaio e uso de um parceiro de ligação marcador-específico? | |
CO2019002607A2 (es) | Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activación por contacto | |
BR112018007842A2 (pt) | imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk) | |
MX2009012048A (es) | Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato. | |
MX2015013596A (es) | Metodos, dispositivos y sistemas para analisis de muestras. | |
DK1989544T3 (da) | T-celle-testmetode | |
WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
WO2011008831A3 (en) | Mass tags for spectrometric analysis of immunoglobulins | |
EA201400571A1 (ru) | Специфичные к трансресвератролу антитела и их применение | |
PE20130526A1 (es) | Componentes de la pared de celulas de levadura y deteccion de los mismos | |
EA201692071A1 (ru) | Иммуноанализ и антитела для обнаружения хромогранина а | |
ES2527703B1 (es) | Inmunosensor electroquímico para la determinación cuantitativa de la micotoxina fb1 | |
CO2019002599A2 (es) | Biomarcadores proteicos para enfermedades asociadas con el sistema de activación por contacto | |
FR2968767B1 (fr) | Procede et coffret pour le diagnostic in vitro du cancer de la prostate | |
CL2009001907A1 (es) | Metodo de deteccion precoz de cancer gastrico que comprende detectar la presencia de marcadores especificos de cancer gastrico en muestras de plasma. | |
MY194325A (en) | Test object detection method, and immunoassay instrument and monoclonal antibody for same | |
BR112018017336A2 (pt) | método in vitro para detectar um anticorpo para p53 (anticorpo anti-p53) em uma amostra e polipeptídeo de fusão |